Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
You can also access detailed information by clicking Login in the website header.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
USA
Regulatory Approval:
Your Trustedworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Farmorubicin (epirubicin) is an anthracycline chemotherapy agent used as part of combination regimens for breast cancer. Farmorubicin is the international brand name; the same active ingredient is marketed in the United States as Ellence.
Epirubicin is approved as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer, typically used in combination with other chemotherapy agents.
Epirubicin intercalates into DNA and inhibits topoisomerase II, disrupting DNA replication and transcription in rapidly dividing cancer cells, leading to cell death.
The typical starting dose is 100 to 120 mg/m², administered intravenously in repeated 3 to 4 week cycles, either as a single dose on Day 1 or divided across Days 1 and 8 of each cycle, as determined by the treating oncologist based on the overall chemotherapy regimen.
Boxed Warning — Farmorubicin: Farmorubicin can cause myocardial toxicity, including congestive heart failure, which may occur during treatment or months to years after completion, with risk increasing with cumulative dose. It can also cause severe myelosuppression, secondary leukemias, and severe local tissue necrosis if extravasation occurs during administration — it must not be given by the intramuscular or subcutaneous route. Dose reduction is required in patients with hepatic impairment.
Cardiac function should be assessed before and periodically during treatment, especially as cumulative dose increases. Risk of cardiomyopathy rises from approximately 0.9% at 550 mg/m² to 3.3% at 900 mg/m² cumulative dose.
Monitor complete blood counts regularly; dose modification may be needed for severe neutropenia or thrombocytopenia.
Secondary acute myeloid leukemia has been reported, particularly with higher cumulative doses.
Administer only by experienced personnel via a free-flowing IV line; extravasation can cause severe tissue damage.
Dose reduction is required in patients with elevated bilirubin or liver enzymes.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
Farmorubicin (epirubicin) is manufactured by Pfizer. Farmorubicin is the international brand name for epirubicin; the same active ingredient is marketed in the United States as Ellence.
Import of Farmorubicin through a Named Patient Program requires a valid prescription from the treating oncologist, breast cancer diagnosis and treatment plan documentation, and supporting clinical documentation as required by Indian regulatory authorities.
NPP sources Farmorubicin directly from Pfizer's authorized supply chain to ensure product authenticity and regulatory compliance.
Farmorubicin is sourced through verified, GDP-compliant, cold-chain channels from Pfizer's authorized supply chain to ensure authenticity and quality.
Farmorubicin should be stored refrigerated at 2°C to 8°C, protected from light. Once the vial is punctured, the solution should be used within 24 hours.
Once sourced, Farmorubicin is packed and transported under continuous cold-chain conditions to preserve product integrity throughout the import process, with tracking and updates provided at each stage of delivery to the patient or treating hospital in India.
Patients across India can access Farmorubicin through NPP's regulated import pathway, with oncology specialists in major cities supporting the treatment process.
Leading oncology centers in Mumbai support breast cancer treatment coordination for Farmorubicin access.
Delhi's major cancer hospitals assist patients with treatment planning and prescription support for Farmorubicin.
Bangalore's oncology network offers access to adjuvant chemotherapy planning for eligible patients.
Chennai-based specialists coordinate Farmorubicin access alongside comprehensive breast cancer care.
Hyderabad's cancer care institutions support patients pursuing Farmorubicin therapy.
Kolkata's oncology centers help coordinate documentation and treatment access for Farmorubicin.
Pune-based oncologists assist with treatment planning for Farmorubicin.
Ahmedabad's specialty hospitals support the import and treatment process for Farmorubicin.
Kochi's oncology units assist patients with the documentation needed for Farmorubicin access.
Chandigarh's cancer care centers support Farmorubicin treatment coordination for patients from North India.
Jaipur's oncology specialists help patients navigate the Farmorubicin access process.
Lucknow-based cancer centers assist patients pursuing Farmorubicin therapy.
Bhubaneswar's oncology institutions support access to Farmorubicin for eligible patients.
Guwahati's specialists help coordinate Farmorubicin access for patients across the Northeast.
Patients in other cities across India can also access Farmorubicin through NPP's nationwide coordination network.
Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 10 September 2026
Sources: FDA • CDSCO
Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 10 September 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
